Tango Therapeutics (TNGX) Change in Acquisitions & Divestments (2020 - 2026)

Tango Therapeutics' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $64.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 17.69% year-over-year to $64.0 million; the TTM figure through Mar 2026 stood at $210.9 million (down 28.84% YoY), while the FY2025 annual figure was $224.6 million, down 31.46% from the prior year.
• Change in Acquisitions & Divestments was $64.0 million for Q1 2026 at Tango Therapeutics, up from $39.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $109.3 million in Q1 2024 to a low of $39.5 million in Q4 2025.
• Historically, Change in Acquisitions & Divestments has averaged $71.3 million across 5 years, with a median of $72.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments soared 106.98% in 2022, then tumbled 53.35% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $82.0 million in 2022, then increased by 3.79% to $85.1 million in 2023, then retreated by 0.43% to $84.7 million in 2024, then sank by 53.35% to $39.5 million in 2025, then surged by 62.04% to $64.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $64.0 million (Q1 2026), $39.5 million (Q4 2025), and $66.0 million (Q3 2025), per Business Quant data.